Poster
42
(#42) Real-World Treatment Patterns of Patients With Schizophrenia Using Oral Olanzapine and the Associated Impact of Non-adherence on Healthcare Resource Utilization
Abstract: Non-adherence to oral antipsychotics is a barrier to optimal outcomes for patients with schizophrenia. This study aimed to identify treatment patterns and the impact of treatment non-adherence on healthcare resource utilization (HCRU) for patients receiving oral olanzapine.
This retrospective study using the US MarketScan Medicaid Claims database included adult patients with schizophrenia (?1 inpatient/?2 outpatient diagnoses;ICD-10:F20) who initiated oral olanzapine (2019ñ2021). Patients had ?1 additional oral olanzapine claim within 90 days. Treatment patterns and HCRU were assessed for adherent (proportion of days covered [PDC]?0.8) and non-adherent (PDC
Sign Up
Psych Congress Network Newsletter
